Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1088601

Prognostic significance of MAPK, Topo IIα and E- cadherin immunoexpression in ovarian serous carcinomas


Šundov, Dinka; Petrić Miše, Branka; Mrklic, Ivana; Bacic, Boris; Vrdoljak, Eduard; Tomic, Snježana
Prognostic significance of MAPK, Topo IIα and E- cadherin immunoexpression in ovarian serous carcinomas // Neoplasma, 64 (2017), 02; 289-298 doi:10.4149/neo_2017_217 (međunarodna recenzija, članak, ostalo)


CROSBI ID: 1088601 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Prognostic significance of MAPK, Topo IIα and E- cadherin immunoexpression in ovarian serous carcinomas

Autori
Šundov, Dinka ; Petrić Miše, Branka ; Mrklic, Ivana ; Bacic, Boris ; Vrdoljak, Eduard ; Tomic, Snježana

Izvornik
Neoplasma (0028-2685) 64 (2017), 02; 289-298

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
Serous ovarian carcinoma, MAPK, Topo IIalpha, E-cadherin, Survival analysis
(serous ovarian carcinoma, MAPK, Topo IIalpha, E-cadherin, survival analysis)

Sažetak
Ovarian cancer accounts for only 3% of all cancers in women but is the most lethal gynaecologic malignancy. Low-grade and high-grade ovarian serous carcinomas (OSCs) represent two different diseases with different prognosis, approaches to detection and treatment. We assessed correlation between, MAPK, topoIIα, E-cadherin immunoexpression and clinicopathological features with overall survival (OS) in OSCs. The study included 81 patients undergoing surgery between January 1995 and December 2005. Formalin fixed paraffin embedded tumour sections were reviewed and examined immunohistochemically using antibodies against MAPK, topoIIα and E-cadherin. The clinicopathological features included: age at surgery, stage according to the criteria of the International Federation of Gynecology and Obstetrics (FIGO), tumour grade, residual disease and vascular invasion. Only ten patients (12.3%) were diagnosed in early FIGO stage of disease. According to morphological criteria, 13.6% of tumor samples were low-grade OSCs and 86.4% were high-grade OSCs. On uninominal analysis, residual disease (p<0.001), E-cadherin (p<0.001), vascular invasion (p=0.002), high-grade morphology (p=0.025) and FIGO stage III-IV (p=0.010) were related to significantly shorter OS. We found no significant association between, MAPK and topoIIα expression and OS. Multinominal analysis revealed that only residual disease (p<0.001) and negative E-cadherin immunoexpression were useful independent predictors of unfavourable clinical outcome and shorter OS.

Izvorni jezik
Engleski



POVEZANOST RADA


Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Šundov, Dinka; Petrić Miše, Branka; Mrklic, Ivana; Bacic, Boris; Vrdoljak, Eduard; Tomic, Snježana
Prognostic significance of MAPK, Topo IIα and E- cadherin immunoexpression in ovarian serous carcinomas // Neoplasma, 64 (2017), 02; 289-298 doi:10.4149/neo_2017_217 (međunarodna recenzija, članak, ostalo)
Šundov, D., Petrić Miše, B., Mrklic, I., Bacic, B., Vrdoljak, E. & Tomic, S. (2017) Prognostic significance of MAPK, Topo IIα and E- cadherin immunoexpression in ovarian serous carcinomas. Neoplasma, 64 (02), 289-298 doi:10.4149/neo_2017_217.
@article{article, author = {\v{S}undov, Dinka and Petri\'{c} Mi\v{s}e, Branka and Mrklic, Ivana and Bacic, Boris and Vrdoljak, Eduard and Tomic, Snje\v{z}ana}, year = {2017}, pages = {289-298}, DOI = {10.4149/neo\_2017\_217}, keywords = {Serous ovarian carcinoma, MAPK, Topo IIalpha, E-cadherin, Survival analysis}, journal = {Neoplasma}, doi = {10.4149/neo\_2017\_217}, volume = {64}, number = {02}, issn = {0028-2685}, title = {Prognostic significance of MAPK, Topo IIα and E- cadherin immunoexpression in ovarian serous carcinomas}, keyword = {Serous ovarian carcinoma, MAPK, Topo IIalpha, E-cadherin, Survival analysis} }
@article{article, author = {\v{S}undov, Dinka and Petri\'{c} Mi\v{s}e, Branka and Mrklic, Ivana and Bacic, Boris and Vrdoljak, Eduard and Tomic, Snje\v{z}ana}, year = {2017}, pages = {289-298}, DOI = {10.4149/neo\_2017\_217}, keywords = {serous ovarian carcinoma, MAPK, Topo IIalpha, E-cadherin, survival analysis}, journal = {Neoplasma}, doi = {10.4149/neo\_2017\_217}, volume = {64}, number = {02}, issn = {0028-2685}, title = {Prognostic significance of MAPK, Topo IIα and E- cadherin immunoexpression in ovarian serous carcinomas}, keyword = {serous ovarian carcinoma, MAPK, Topo IIalpha, E-cadherin, survival analysis} }

Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font